Pretomanid is a newly approved drug for treatment of highly resistant TB. Used in combination with linezolid and bedaquiline it can address cases of multi drug resistant renal TB we see in our environment. Expensive but costs will improve with time. #progress #MDRTB #renalTB (at Ikeja) https://www.instagram.com/p/B6nf7ypF3hx/?igshid=19md55zglyo3











